Literature DB >> 20972472

Antigen-presenting cell function in the tolerogenic liver environment.

Angus W Thomson1, Percy A Knolle.   

Abstract

The demands that are imposed on the liver as a result of its function as a metabolic organ that extracts nutrients and clears gut-derived microbial products from the blood are met by a unique microanatomical and immunological environment. The inherent tolerogenicity of the liver and its role in the regulation of innate and adaptive immunity are mediated by parenchymal and non-parenchymal antigen-presenting cells (APCs), cell-autonomous molecular pathways and locally produced factors. Here, we review the central role of liver APCs in the regulation of hepatic immune function and also consider how recent insights may be applied in strategies to target liver tolerance for disease therapy.

Mesh:

Year:  2010        PMID: 20972472     DOI: 10.1038/nri2858

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  161 in total

1.  Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition.

Authors:  Venu G Pillarisetty; Alaap B Shah; George Miller; Joshua I Bleier; Ronald P DeMatteo
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

2.  Type I IFN-producing CD4 Valpha14i NKT cells facilitate priming of IL-10-producing CD8 T cells by hepatocytes.

Authors:  Christian Wahl; Petra Bochtler; Reinhold Schirmbeck; Jörg Reimann
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

3.  Role of Kupffer cells in the induction of tolerance after liver transplantation.

Authors:  K Sato; K Yabuki; T Haba; T Maekawa
Journal:  J Surg Res       Date:  1996-07-01       Impact factor: 2.192

4.  Increased infiltration of intrahepatic DC subsets closely correlate with viral control and liver injury in immune active pediatric patients with chronic hepatitis B.

Authors:  Zheng Zhang; Dawei Chen; Jinxia Yao; Hui Zhang; Lei Jin; Ming Shi; Hongfei Zhang; Fu-Sheng Wang
Journal:  Clin Immunol       Date:  2006-10-18       Impact factor: 3.969

5.  Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice.

Authors:  Manabu Kinoshita; Takefumi Uchida; Atsushi Sato; Masahiro Nakashima; Hiroyuki Nakashima; Satoshi Shono; Yoshiko Habu; Hiromi Miyazaki; Sadayuki Hiroi; Shuhji Seki
Journal:  J Hepatol       Date:  2010-07-14       Impact factor: 25.083

Review 6.  Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance.

Authors:  Melissa Swiecki; Marco Colonna
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

7.  A critical role of TRAIL expressed on cotransplanted hepatic stellate cells in prevention of islet allograft rejection.

Authors:  Horng-Ren Yang; Ching-Chuan Hsieh; Lianfu Wang; John J Fung; Lina Lu; Shiguang Qian
Journal:  Microsurgery       Date:  2010-05       Impact factor: 2.425

8.  The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity.

Authors:  David G Bowen; Monica Zen; Lauren Holz; Thomas Davis; Geoffrey W McCaughan; Patrick Bertolino
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

9.  Kupffer cell-mediated recruitment of dendritic cells to the liver crucial for a host defense.

Authors:  Kenjiro Matsuno; Hisayuki Nomiyama; Hiroyuki Yoneyama; Ryosuke Uwatoku
Journal:  Dev Immunol       Date:  2002-09

10.  Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection.

Authors:  Abhishek Das; Matthew Hoare; Nathan Davies; A Ross Lopes; Claire Dunn; Patrick T F Kennedy; Graeme Alexander; Helene Finney; Alistair Lawson; Fiona J Plunkett; Antonio Bertoletti; Arne N Akbar; Mala K Maini
Journal:  J Exp Med       Date:  2008-08-11       Impact factor: 14.307

View more
  270 in total

Review 1.  Why some organ allografts are tolerated better than others: new insights for an old question.

Authors:  Travis D Hull; Gilles Benichou; Joren C Madsen
Journal:  Curr Opin Organ Transplant       Date:  2019-02       Impact factor: 2.640

Review 2.  Role of interleukin-21 in HBV infection: friend or foe?

Authors:  Yongyin Li; Libo Tang; Jinlin Hou
Journal:  Cell Mol Immunol       Date:  2014-11-03       Impact factor: 11.530

Review 3.  Dissecting the dendritic cell controversy in chronic hepatitis B virus infection.

Authors:  Adam J Gehring; June Ann D'Angelo
Journal:  Cell Mol Immunol       Date:  2014-11-03       Impact factor: 11.530

4.  The role of pDC, recipient T(reg) and donor T(reg) in HSC engraftment: Mechanisms of facilitation.

Authors:  Paul A Cardenas; Yiming Huang; Suzanne T Ildstad
Journal:  Chimerism       Date:  2011-07-01

5.  Use of Polymeric Nanoparticle Platform Targeting the Liver To Induce Treg-Mediated Antigen-Specific Immune Tolerance in a Pulmonary Allergen Sensitization Model.

Authors:  Qi Liu; Xiang Wang; Xiangsheng Liu; Sanjan Kumar; Grant Gochman; Ying Ji; Yu-Pei Liao; Chong Hyun Chang; Wesley Situ; Jianqin Lu; Jinhong Jiang; Kuo-Ching Mei; Huan Meng; Tian Xia; Andre E Nel
Journal:  ACS Nano       Date:  2019-04-12       Impact factor: 15.881

Review 6.  Myeloid Cells and Chronic Liver Disease: a Comprehensive Review.

Authors:  Min Lian; Carlo Selmi; M Eric Gershwin; Xiong Ma
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

7.  Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection.

Authors:  Li-Rung Huang; Dirk Wohlleber; Florian Reisinger; Craig N Jenne; Ru-Lin Cheng; Zeinab Abdullah; Frank A Schildberg; Margarete Odenthal; Hans-Peter Dienes; Nico van Rooijen; Edgar Schmitt; Natalio Garbi; Michael Croft; Christian Kurts; Paul Kubes; Ulrike Protzer; Mathias Heikenwalder; Percy A Knolle
Journal:  Nat Immunol       Date:  2013-04-14       Impact factor: 25.606

8.  DAP12 deficiency in liver allografts results in enhanced donor DC migration, augmented effector T cell responses and abrogation of transplant tolerance.

Authors:  O Yoshida; S Kimura; L Dou; B M Matta; S Yokota; M A Ross; D A Geller; A W Thomson
Journal:  Am J Transplant       Date:  2014-06-16       Impact factor: 8.086

9.  Liver microRNA Profile of Induced Allograft Tolerance.

Authors:  Matthew James Vitalone; Liang Wei; Masato Fujiki; Audrey H Lau; Erik Littau; Carlos Esquivel; Olivia M Martinez; Sheri M Krams
Journal:  Transplantation       Date:  2016-04       Impact factor: 4.939

10.  Potentiating cancer vaccine efficacy in liver cancer.

Authors:  Maria Tagliamonte; Annacarmen Petrizzo; Angela Mauriello; Maria Lina Tornesello; Franco M Buonaguro; Luigi Buonaguro
Journal:  Oncoimmunology       Date:  2018-07-23       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.